Correlation Between Styrenix Performance and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Styrenix Performance and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Styrenix Performance and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Styrenix Performance Materials and Beta Drugs, you can compare the effects of market volatilities on Styrenix Performance and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Styrenix Performance with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Styrenix Performance and Beta Drugs.

Diversification Opportunities for Styrenix Performance and Beta Drugs

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Styrenix and Beta is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Styrenix Performance Materials and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Styrenix Performance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Styrenix Performance Materials are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Styrenix Performance i.e., Styrenix Performance and Beta Drugs go up and down completely randomly.

Pair Corralation between Styrenix Performance and Beta Drugs

Assuming the 90 days trading horizon Styrenix Performance is expected to generate 9.35 times less return on investment than Beta Drugs. But when comparing it to its historical volatility, Styrenix Performance Materials is 1.98 times less risky than Beta Drugs. It trades about 0.03 of its potential returns per unit of risk. Beta Drugs is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  197,130  in Beta Drugs on September 2, 2024 and sell it today you would earn a total of  20,055  from holding Beta Drugs or generate 10.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Styrenix Performance Materials  vs.  Beta Drugs

 Performance 
       Timeline  
Styrenix Performance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Styrenix Performance Materials has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Styrenix Performance is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.
Beta Drugs 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Styrenix Performance and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Styrenix Performance and Beta Drugs

The main advantage of trading using opposite Styrenix Performance and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Styrenix Performance position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Styrenix Performance Materials and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format